Literature DB >> 22732042

Do living kidney donors have CKD?

Titte R Srinivas1, Emilio D Poggio.   

Abstract

Living kidney donor transplantation is an increasingly used treatment for end-stage renal disease because it both confers excellent outcomes to transplant recipients, and is considered a safe procedure for prospective donors. The short- and long-term safety of prospective donors is paramount to the continued success of living donation. Although the initial experience with living kidney donors mostly included the healthiest donors, increasing need for organs and secular trends in the general population have subtly reshaped prevailing suitability criteria for donation. As the practice of living donation evolved over time, our understanding of kidney disease has also changed as we embraced the framework of the K-DOQI guidelines. It is not uncommon for donors to fit into some of the K-DOQI guidelines paradigms of risk and disease; however, whether there is a true biological consequence or whether it is a merely semantic conundrum remains unclear. Regardless, this is an important issue, and therefore future efforts should aim at addressing this matter.
Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22732042     DOI: 10.1053/j.ackd.2012.05.008

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  7 in total

1.  Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer.

Authors:  Daniel Vergho; Maximilian Burger; Moritz Schrammel; Sabine Brookman-May; Michael Gierth; Bernd Hoschke; Kai Lopau; Christian Gilfrich; Hubertus Riedmiller; Ingmar Wolff; Matthias May
Journal:  World J Urol       Date:  2014-10-25       Impact factor: 4.226

2.  Gout after living kidney donation: correlations with demographic traits and renal complications.

Authors:  Ngan N Lam; Amit X Garg; Dorry L Segev; Mark A Schnitzler; Huiling Xiao; David Axelrod; Daniel C Brennan; Bertram L Kasiske; Janet E Tuttle-Newhall; Krista L Lentine
Journal:  Am J Nephrol       Date:  2015-04-17       Impact factor: 3.754

Review 3.  Long-term medical risks to the living kidney donor.

Authors:  Ngan N Lam; Krista L Lentine; Andrew S Levey; Bertram L Kasiske; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2015-05-05       Impact factor: 28.314

Review 4.  Risk for cancer in living kidney donors and recipients.

Authors:  Min Wang; Huai Zhang; Dan Zhou; Yong-Chao Qiao; Yan-Hong Pan; Yan-Chao Wang; Hai-Lu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-22       Impact factor: 4.553

5.  The Outcomes of Living Kidney Donation from Medically Complex Donors: Implications for the Donor and the Recipient.

Authors:  Matthew Niemi; Didier A Mandelbrot
Journal:  Curr Transplant Rep       Date:  2014-03-01

Review 6.  Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?

Authors:  Charles J Ferro; Jonathan N Townend
Journal:  Clin Kidney J       Date:  2021-12-13

7.  Baseline living-donor kidney volume and function associate with 1-year post-nephrectomy kidney function.

Authors:  Isaac E Hall; Akram Shaaban; Guo Wei; Magdalena B Sikora; Hassan Bourija; Srinivasan Beddhu; Fuad Shihab
Journal:  Clin Transplant       Date:  2019-02-12       Impact factor: 2.863

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.